Biopharmaceuticals
Our Capabilities
By Service
Product Design Clinical Trial Materials & Services Finished Dosage Forms Capsules
By Challenge
Bioavailability Enhancement Targeted Delivery Inhalation Formulation Lipid & Liquid Based Formulations Taste & Odor Masking Browse All
By Technology
Spray Dried Dispersion Inhalation Technology Lipid Multiparticulate Technology Liquid Filled Hard Capsule Technology Micronization Browse All
By Product Development Site
Bend, Oregon, USA Edinburgh, Scotland Ploërmel, France Tampa, Florida, USA Browse All
How We Work
Our Process
Project Lifecycle Support
Quality & Regulatory
Quality & Responsibility Regulatory Assistance
Facilities & Locations
Meet the team at our Bend, Oregon, USA facility

Meet the team at our Bend, Oregon, USA facility

 Browse All
Contact Us

Locations & Facilities

Consumer Health & Nutrition
Our Capabilities
By Market Opportunity
Herbs & Botanicals Digestive Health Clean Label Healthy Aging Vegetarian Products Browse All
By Product Type
Empty Vegetarian Capsules Filled Hard Capsules Functional Capsules Taste & Odor Masking Ingredients & Intermediates Browse All
Trending Now
Lonza Completes Acquisition Of Capsugel To Create Leading Integrated Solutions Provider To The Global Pharma And Consumer Healthcare Industries Cultivate Your Probiotic Performance: Market Trends and Innovative Solutions Vegetarian Products Healthy Aging
Working With Capsugel
Custom Solutions
Market & Consumer Insights Formulation Support Manufacturing & Technical Services Building Your Brand Encapsulation Equipment
Quality & Regulatory
Capsule Quality Product Certifications Quality & Responsibility Regulatory Assistance
Facilities & Locations
Meet the team at our Bend, Oregon, USA facility

Meet the team at our Bend, Oregon, USA facility

 Browse All
Contact Us

Locations & Facilities

About Us
Overview
About Capsugel Now a Lonza Company Earning Trust Quality & Responsibility Regulatory Assistance Careers
News & Events
News Events & Webinars In The News Media Inquiries
Contact Us

Locations & Facilities

Knowledge Center
English
Chinese Japanese Portuguese Russian
Contact Us
Type To Search

Leading the way in capsule-based DPIs through customization with the Capsugel® Zephyr™ portfolio

Frederique Bordes-Picard, CPhI Worldwide 2019 presentation

According to the World Health Organization, an estimated 65 million people worldwide have moderate to severe COPD. Capsule-based DPI products offer multiple benefits to those suffering from COPD. 

In her presentation from CPhI Worldwide 2019, Frederique Bordes-Picard, Business Development Manager at Lonza, discusses the benefits of dry-powder inhalation technology, industry trends and our Capsugel® Zephyr™ portfolio.


Watch and download the presentation below.
Download
Lonza Engine™ equipment portfolio for small molecule bioavailability enhancement, particle engineering and drug product development
December 08, 2019
View
Quality by Design and Continuous Improvement as a basis for high product quality
December 08, 2019
View
On-Demand Webinar: Discover the Capsugel® Zephyr™ DPI Portfolio
December 08, 2019
View
Capsugel® Zephyr™

Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication.

Capsugel® Zephyr™

Privacy and Cookies Notice

Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.

We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.

By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.

To View, Please Provide the Following

To access all of the latest news, white papers, webinars and knowledge center resources, Create An Account. Already have a Capsugel account? Log In

Privacy Policy

To view this item, Sign Up for a free account

Get access to the latest news, additional whitepapers, webinars and Knowledge Center content. Already have an account? Log In

Privacy Policy

Thanks for creating an account with Capsugel!

You now have access to the latest news, whitepapers, webinars and Knowledge Center content.

Thanks for contacting Capsugel

A representative will be in touch.

Continue Browsing Privacy Policy
Biopharmaceuticals
Our Capabilities Product Design Clinical Trial Materials & Services Finished Dosage Forms Capsules How We Work Project Lifecycle Support Quality Assurance Regulatory Assistance
Consumer Health & Nutrition
Our Capabilities Market Opportunities Product Portfolio Working With Capsugel Formulation Support Manufacturing & Technical Services Building Your Brand Encapsulation Equipment Capsule Quality Product Certifications Quality and Responsibility Regulatory Assistance
About Us
About Capsugel Now A Lonza Company Earning Trust Quality & Responsibility Regulatory Assistance News Events & Webinars Locations & Facilities Careers Contact Us
Knowledge Center